In Silico Design of Multimeric HN-F Antigen as a Highly Immunogenic Peptide Vaccine Against Newcastle Disease Virus

Application of molecular biology techniques to the production of new vaccines against different strains of the Newcastle disease virus (NDV) has been the subject of recent research reports. Development of improved techniques for genome sequencing has led to the recognition of protective mechanisms a...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of peptide research and therapeutics Vol. 20; no. 2; pp. 179 - 194
Main Authors Motamedi, Mohammad Javad, Amani, Jafar, Shahsavandi, Shahla, Salmanian, Ali Hatef
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.06.2014
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Application of molecular biology techniques to the production of new vaccines against different strains of the Newcastle disease virus (NDV) has been the subject of recent research reports. Development of improved techniques for genome sequencing has led to the recognition of protective mechanisms and the identification of possible candidate antigens. Such procedures could generate meaningful results regarding the virulence determinants of NDV. This study proposed an in silico approach by assembling potential and conserved epitopic regions of hemagglutinin–neuraminidase (HN) and fusion (F) glycoproteins of NDV to induce multiepitopic responses against the virus. Epitope predictions showed that the hypothetical synthetic construct could induce immature B and T cell epitopes that expect a high immune response because of their location in four distinct parts of the construct, namely the head, stalk and the heptad repeated regions known as the HRA and HRB domains. Most regions of the chimeric construct were found to have high antigenic propensity and surface accessibility, which further confirmed the strategy for selection of precise continuous and discontinuous epitopes of HN and F antigens. Thermodynamic folding of mRNA structures revealed correct folding of the RNA construct, indicating good stability of the mRNA to increase the efficiency of translation in the target host. The three-dimensional structure of the native HN-F chimeric protein was successfully generated and validated as a proper model which may define reliability, structural quality and conformation.
AbstractList Application of molecular biology techniques to the production of new vaccines against different strains of the Newcastle disease virus (NDV) has been the subject of recent research reports. Development of improved techniques for genome sequencing has led to the recognition of protective mechanisms and the identification of possible candidate antigens. Such procedures could generate meaningful results regarding the virulence determinants of NDV. This study proposed an in silico approach by assembling potential and conserved epitopic regions of hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins of NDV to induce multiepitopic responses against the virus. Epitope predictions showed that the hypothetical synthetic construct could induce immature B and T cell epitopes that expect a high immune response because of their location in four distinct parts of the construct, namely the head, stalk and the heptad repeated regions known as the HRA and HRB domains. Most regions of the chimeric construct were found to have high antigenic propensity and surface accessibility, which further confirmed the strategy for selection of precise continuous and discontinuous epitopes of HN and F antigens. Thermodynamic folding of mRNA structures revealed correct folding of the RNA construct, indicating good stability of the mRNA to increase the efficiency of translation in the target host. The three-dimensional structure of the native HN-F chimeric protein was successfully generated and validated as a proper model which may define reliability, structural quality and conformation.
Application of molecular biology techniques to the production of new vaccines against different strains of the Newcastle disease virus (NDV) has been the subject of recent research reports. Development of improved techniques for genome sequencing has led to the recognition of protective mechanisms and the identification of possible candidate antigens. Such procedures could generate meaningful results regarding the virulence determinants of NDV. This study proposed an in silico approach by assembling potential and conserved epitopic regions of hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins of NDV to induce multiepitopic responses against the virus. Epitope predictions showed that the hypothetical synthetic construct could induce immature B and T cell epitopes that expect a high immune response because of their location in four distinct parts of the construct, namely the head, stalk and the heptad repeated regions known as the HRA and HRB domains. Most regions of the chimeric construct were found to have high antigenic propensity and surface accessibility, which further confirmed the strategy for selection of precise continuous and discontinuous epitopes of HN and F antigens. Thermodynamic folding of mRNA structures revealed correct folding of the RNA construct, indicating good stability of the mRNA to increase the efficiency of translation in the target host. The three-dimensional structure of the native HN-F chimeric protein was successfully generated and validated as a proper model which may define reliability, structural quality and conformation.[PUBLICATION ABSTRACT]
Author Shahsavandi, Shahla
Amani, Jafar
Salmanian, Ali Hatef
Motamedi, Mohammad Javad
Author_xml – sequence: 1
  givenname: Mohammad Javad
  surname: Motamedi
  fullname: Motamedi, Mohammad Javad
  organization: Department of Plant Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB)
– sequence: 2
  givenname: Jafar
  surname: Amani
  fullname: Amani, Jafar
  organization: Applied Microbiology Research Center, Baqiyatallah Medical Science University
– sequence: 3
  givenname: Shahla
  surname: Shahsavandi
  fullname: Shahsavandi, Shahla
  organization: Razi Vaccine and Serum Research Institute
– sequence: 4
  givenname: Ali Hatef
  surname: Salmanian
  fullname: Salmanian, Ali Hatef
  email: salman@nigeb.ac.ir
  organization: Department of Plant Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB)
BookMark eNp9kd9rFDEQx4O0YFv9A3wL-OLLan7c7iaPR2u9g1oLrb6GXHaypuwmZyaL7X9vyilIQZ9mGD6fmYHvKTmKKQIhbzh7zxnrPyBnWumGcdloqVjz8IKc8LaXjdRsdfSn5yv9kpwi3jPWip6zE4LbSG_DFFyiF4BhjDR5-nmZSpghB0c3180lXccSRojUIrV0E8bv0yPdzvMSU51W6Ab2JQxAv1nnQgS6Hm2IWOg1_HQWywT0IiBYrETIC74ix95OCK9_1zPy9fLj3fmmufryaXu-vmqcXOnSDEMrexiU58POeZC9VLrvVdc58Nrtuta2QmghHFjugQvGOs1VK7wXfMe0lWfk3WHvPqcfC2Axc0AH02QjpAUNbwWTquNaVfTtM_Q-LTnW7yrFhRKStbxS_EC5nBAzeLPPYbb50XBmnmIwhxhMjcE8xWAeqtM_c1wotoQUS7Zh-q8pDibWK3GE_NdP_5R-AWeIni8
CitedBy_id crossref_primary_10_1007_s11248_021_00295_2
crossref_primary_10_1007_s40203_024_00292_3
crossref_primary_10_1016_j_molliq_2020_113612
crossref_primary_10_3390_vaccines10030378
crossref_primary_10_1186_s43141_022_00357_w
crossref_primary_10_3103_S0891416816030022
crossref_primary_10_1007_s12033_020_00254_y
crossref_primary_10_3390_vaccines10081192
crossref_primary_10_1016_j_virusres_2019_197750
crossref_primary_10_1007_s10989_019_09952_x
Cites_doi 10.1128/CMR.00005-07
10.1016/S0167-7799(01)01670-5
10.1128/JVI.78.8.4176-4184.2004
10.1016/j.vaccine.2006.08.016
10.1093/protein/15.11.871
10.1186/1742-4682-6-28
10.1016/j.tibtech.2004.04.006
10.1093/nar/12.2.857
10.1016/S1386-6532(99)00072-4
10.1186/1471-2105-9-40
10.1093/protein/14.8.529
10.1002/prot.10286
10.1177/104063870802000402
10.1186/1297-9716-42-122
10.1016/j.vaccine.2009.09.095
10.1016/0022-2836(81)90003-6
10.1016/j.mimet.2012.04.001
10.1006/viro.1995.1497
10.1016/j.meegid.2009.09.012
10.1128/JVI.78.24.13727-13742.2004
10.1007/s00726-010-0830-x
10.1016/S1093-3263(00)00138-8
10.1111/j.1467-7652.2009.00497.x
10.1007/s00239-004-0277-3
10.1073/pnas.1111691108
10.1038/nbt0591-443
10.1007/s11250-010-9638-7
10.1007/s00299-011-1065-3
10.1007/s11095-006-9059-5
10.1016/0014-5793(90)80535-Q
10.1142/S0129183103005327
10.1007/s11095-008-9767-0
10.1016/j.sbi.2007.08.016
10.1099/0022-1317-70-11-3105
10.1038/35105075
10.1016/S1367-5931(00)00208-8
10.1021/bi00367a013
10.1586/erv.10.83
10.1155/2012/708216
10.1093/ps/82.6.899
10.1083/jcb.108.2.229
10.1016/S0097-8485(00)80008-X
10.1136/vr.140.1.20
10.1006/viro.2001.0899
10.1186/1471-2105-8-4
10.1093/bib/bbq008
10.4155/fmc.10.6
10.1016/0014-5793(90)80392-V
10.1016/j.ymeth.2004.06.004
10.1093/molbev/msl148
10.1093/nar/15.3.1281
10.2741/1187
10.1016/j.jchromb.2009.10.009
10.1038/nature04322
10.18553/jmcp.2007.13.s7-b.12
10.5772/26675
10.1016/j.vaccine.2005.01.059
10.1128/JVI.55.3.836-839.1985
10.1128/JVI.65.9.4999-5006.1991
ContentType Journal Article
Copyright Springer Science+Business Media New York 2013
Springer Science+Business Media New York 2014
Copyright_xml – notice: Springer Science+Business Media New York 2013
– notice: Springer Science+Business Media New York 2014
DBID AAYXX
CITATION
3V.
7X7
7XB
88A
88I
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M2P
M7P
PHGZM
PHGZT
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7T5
7U9
H94
DOI 10.1007/s10989-013-9380-x
DatabaseName CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central (New) (NC LIVE)
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
ProQuest One Academic (New)
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
DatabaseTitleList AIDS and Cancer Research Abstracts
ProQuest Central Student

Database_xml – sequence: 1
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1573-3904
EndPage 194
ExternalDocumentID 3266930201
10_1007_s10989_013_9380_x
Genre Feature
GroupedDBID ---
-56
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
2.D
203
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3V.
4.4
406
408
409
40E
53G
5GY
5VS
67N
67Z
6NX
7X7
88A
88I
8AO
8CJ
8FE
8FH
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACGOD
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACUHS
ACZOJ
ADBBV
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYPR
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFGCZ
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBNVY
BDATZ
BENPR
BGNMA
BHPHI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
D1J
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EN4
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GXS
H13
HCIFZ
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LK8
LLZTM
M0L
M2P
M4Y
M7P
MA-
NB0
NDZJH
NPVJJ
NQJWS
NU0
O93
O9G
O9I
O9J
OAM
OVD
P19
PF0
PQQKQ
PROAC
PT4
PT5
Q2X
QOR
QOS
R89
R9I
RNS
ROL
RPX
RSV
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SCLPG
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z87
Z8O
Z91
ZMTXR
ZOVNA
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
7XB
8FK
ABRTQ
K9.
PKEHL
PQEST
PQGLB
PQUKI
PRINS
Q9U
7T5
7U9
H94
ID FETCH-LOGICAL-c349t-dd537ed8f1dbcfe3738977866cef9cb65a522922cea1fe1200691852ff21b09a3
IEDL.DBID U2A
ISSN 1573-3149
IngestDate Fri Jul 11 03:46:09 EDT 2025
Fri Jul 25 19:17:09 EDT 2025
Tue Jul 01 02:21:32 EDT 2025
Thu Apr 24 23:07:36 EDT 2025
Fri Feb 21 02:26:12 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Epitope mapping
Peptide vaccine
Newcastle disease virus
Codon optimization
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c349t-dd537ed8f1dbcfe3738977866cef9cb65a522922cea1fe1200691852ff21b09a3
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-2
content type line 23
PQID 1512823051
PQPubID 54427
PageCount 16
ParticipantIDs proquest_miscellaneous_1520386198
proquest_journals_1512823051
crossref_primary_10_1007_s10989_013_9380_x
crossref_citationtrail_10_1007_s10989_013_9380_x
springer_journals_10_1007_s10989_013_9380_x
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-06-01
PublicationDateYYYYMMDD 2014-06-01
PublicationDate_xml – month: 06
  year: 2014
  text: 2014-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
PublicationSubtitle formerly known as "Letters in Peptide Science"
PublicationTitle International journal of peptide research and therapeutics
PublicationTitleAbbrev Int J Pept Res Ther
PublicationYear 2014
Publisher Springer Netherlands
Springer Nature B.V
Publisher_xml – name: Springer Netherlands
– name: Springer Nature B.V
References Balen, Krsnik-Rasol (CR8) 2007; 45
Irving, Pan, Scott (CR31) 2001; 5
Iorio, Syddall, Sheehan, Bratt, Glickman, Riel (CR30) 1991; 65
Lamb, Kolakofsky, Knipe, Howley (CR38) 2001
Sinkovics, Horvath (CR53) 2000; 16
Susta, Miller, Afonso, Estevez, Yu, Zhang, Brown (CR56) 2010; 42
Lovell, Davis, Arendall, De Bakker, Word, Prisant, Richardson, Richardson (CR39) 2003; 50
Xiao, Huang, Xiao (CR61) 2003; 14
Soria-Guerra, Moreno-Fierros, Rosales-Mendoza (CR54) 2011; 30
Sharp, Li (CR52) 1987; 15
De Groot, Berzofsky (CR14) 2004; 34
Dunker, Lawson, Brown, Williams, Romero, Oh, Oldfield, Campen, Ratliff, Hipps, Ausio, Nissen, Reeves, Kang, Kissinger, Bailey, Griswold, Chiu, Garner, Obradovic (CR18) 2001; 19
Ikemura (CR29) 1981; 151
Henry, Sharp (CR25) 2007; 24
Amet, Lee, Shen (CR3) 2009; 26
Arai, Ueda, Kitayama, Kamiya, Nagamune (CR5) 2001; 14
Ryan, Daly, Mills (CR51) 2001; 19
Wang, Wu, Negre, White, Li, Shah (CR58) 2011; 12
Nazarian, Mousavi Gargari, Rasooli, Amani, Bagheri, Alerasool (CR45) 2012; 90
Wilkinson, Harrison (CR59) 1991; 9
Bai, Shen (CR7) 2006; 23
Yang, Liu, Pan, Yu, Jiao (CR62) 2007; 25
Earp, Delos, Park, White (CR19) 2005; 285
CR49
Gomord, Fitchette, Menu-Bouaouiche, Saint-Jore-Dupas, Plasson, Michaud, Faye (CR22) 2010; 8
Hines, Miller (CR26) 2012; 2012
De Groot, McMurry, Marcon, Franco, Rivera, Kutzler, Weiner, Martin (CR15) 2005; 23
Kukic, Nielsen (CR35) 2010; 2
CR46
Angenon, Van Montagu, Depicker (CR4) 1990; 271
Amani, Mousavi, Rafati, Salmanian (CR2) 2009; 6
Lakshmi, Subhashini (CR36) 2010; 2
Dortmans, Koch, Rottier, Peeters (CR16) 2011; 42
Huang, Elankumaran, Panda, Samal (CR27) 2003; 82
Huang, Panda, Elankumaran, Govindarajan, Rockemann, Samal (CR28) 2004; 78
Meeusen, Walker, Peters, Pastoret, Jungersen (CR42) 2007; 20
Lamb, Jardetzky (CR37) 2007; 17
McGinnes, Sergel, Reitter, Morrison (CR41) 2001; 283
Yin, Wen, Paterson, Lamb, Jardetzky (CR63) 2006; 439
Gustafsson, Govindarajan, Minshull (CR24) 2004; 22
Kozak (CR34) 1989; 108
Bashford (CR10) 2004; 9
Berzofsky, Ahlers, Belyakov (CR11) 2001; 1
Rosenberg (CR48) 2005
Gupta, Singh, Srivastava, Akhoon (CR23) 2009; 28
Kolaskar, Tongaonkar (CR32) 1990; 276
Parker, Guo, Hodges (CR47) 1986; 25
Alexander, Manvell, Frost, Pollitt, Welchman, Perry (CR1) 1997; 140
Doytchinova, Flower (CR17) 2007; 8
Wu, Fan, Li (CR60) 2009; 877
Yusoff, Nesbit, McCartney, Meulemans, Alexander, Collins, Emmerson, Samson (CR65) 1989; 70
Armstrong (CR6) 2007; 13
Chen, Zaro, Shen (CR13) 2012
Miller, Decanini, Afonso (CR44) 2010; 10
Sun, Chen, Xu, Luo (CR55) 2005; 61
George, Heringa (CR21) 2002; 15
Yuan, Swanson, Leser, Paterson, Lamb, Jardetzky (CR64) 2011; 108
Emini, Hughes, Perlow, Boger (CR20) 1985; 55
Bosch, Schots (CR12) 2010; 9
Baloria, Akhoon, Gupta, Sharma, Verma (CR9) 2012; 42
Mia Kim, Suarez, Afonso (CR43) 2008; 20
Wan, Wootton (CR57) 2000; 24
Zhang (CR66) 2008; 9
Russell, Jardetzky, Lamb (CR50) 2004; 78
Kozak (CR33) 1984; 12
McGinnes, Morrison (CR40) 1995; 212
DJ Alexander (9380_CR1) 1997; 140
9380_CR46
J Sun (9380_CR55) 2005; 61
M Kozak (9380_CR33) 1984; 12
L Susta (9380_CR56) 2010; 42
D Bosch (9380_CR12) 2010; 9
JG Sinkovics (9380_CR53) 2000; 16
SC Lovell (9380_CR39) 2003; 50
P Yuan (9380_CR64) 2011; 108
X Chen (9380_CR13) 2012
RA Lamb (9380_CR37) 2007; 17
LW McGinnes (9380_CR40) 1995; 212
IIM Rosenberg (9380_CR48) 2005
LW McGinnes (9380_CR41) 2001; 283
C Gustafsson (9380_CR24) 2004; 22
CJ Russell (9380_CR50) 2004; 78
DL Wilkinson (9380_CR59) 1991; 9
B Balen (9380_CR8) 2007; 45
PM Sharp (9380_CR52) 1987; 15
Y Zhang (9380_CR66) 2008; 9
AS Groot De (9380_CR15) 2005; 23
V Gomord (9380_CR22) 2010; 8
T Ikemura (9380_CR29) 1981; 151
J Amani (9380_CR2) 2009; 6
Z Huang (9380_CR28) 2004; 78
JM Parker (9380_CR47) 1986; 25
D Bashford (9380_CR10) 2004; 9
EN Meeusen (9380_CR42) 2007; 20
MB Irving (9380_CR31) 2001; 5
PTV Lakshmi (9380_CR36) 2010; 2
P Kukic (9380_CR35) 2010; 2
K Yusoff (9380_CR65) 1989; 70
AS Kolaskar (9380_CR32) 1990; 276
L Mia Kim (9380_CR43) 2008; 20
EJ Ryan (9380_CR51) 2001; 19
LJ Earp (9380_CR19) 2005; 285
JC Dortmans (9380_CR16) 2011; 42
EP Armstrong (9380_CR6) 2007; 13
PJ Miller (9380_CR44) 2010; 10
N Amet (9380_CR3) 2009; 26
R Arai (9380_CR5) 2001; 14
I Henry (9380_CR25) 2007; 24
YJ Wu (9380_CR60) 2009; 877
H Wan (9380_CR57) 2000; 24
G Angenon (9380_CR4) 1990; 271
Z Huang (9380_CR27) 2003; 82
RA Lamb (9380_CR38) 2001
NL Hines (9380_CR26) 2012; 2012
S Xiao (9380_CR61) 2003; 14
SK Gupta (9380_CR23) 2009; 28
IA Doytchinova (9380_CR17) 2007; 8
EA Emini (9380_CR20) 1985; 55
RE Soria-Guerra (9380_CR54) 2011; 30
ZQ Yang (9380_CR62) 2007; 25
AS Groot De (9380_CR14) 2004; 34
S Nazarian (9380_CR45) 2012; 90
HS Yin (9380_CR63) 2006; 439
Y Wang (9380_CR58) 2011; 12
JA Berzofsky (9380_CR11) 2001; 1
M Kozak (9380_CR34) 1989; 108
U Baloria (9380_CR9) 2012; 42
RM Iorio (9380_CR30) 1991; 65
RA George (9380_CR21) 2002; 15
9380_CR49
Y Bai (9380_CR7) 2006; 23
AK Dunker (9380_CR18) 2001; 19
References_xml – volume: 20
  start-page: 489
  issue: 3
  year: 2007
  end-page: 510
  ident: CR42
  article-title: Current status of veterinary vaccines
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00005-07
– volume: 19
  start-page: 293
  issue: 8
  year: 2001
  end-page: 304
  ident: CR51
  article-title: Immunomodulators and delivery systems for vaccination by mucosal routes
  publication-title: Trends Biotechnol
  doi: 10.1016/S0167-7799(01)01670-5
– ident: CR49
– volume: 78
  start-page: 4176
  issue: 8
  year: 2004
  end-page: 4184
  ident: CR28
  article-title: The hemagglutinin–neuraminidase protein of Newcastle disease virus determines tropism and virulence
  publication-title: J Virol
  doi: 10.1128/JVI.78.8.4176-4184.2004
– volume: 25
  start-page: 591
  issue: 4
  year: 2007
  end-page: 598
  ident: CR62
  article-title: Expression of the fusion glycoprotein of Newcastle disease virus in transgenic rice and its immunogenicity in mice
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.08.016
– volume: 15
  start-page: 871
  issue: 11
  year: 2002
  end-page: 879
  ident: CR21
  article-title: An analysis of protein domain linkers: their classification and role in protein folding
  publication-title: Protein Eng
  doi: 10.1093/protein/15.11.871
– volume: 6
  start-page: 28
  year: 2009
  ident: CR2
  article-title: In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications
  publication-title: Theor Biol Med Model
  doi: 10.1186/1742-4682-6-28
– volume: 65
  start-page: 4999
  issue: 9
  year: 1991
  end-page: 5006
  ident: CR30
  article-title: Neutralization map of the hemagglutinin–neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition
  publication-title: J Virol
– volume: 22
  start-page: 346
  issue: 7
  year: 2004
  end-page: 353
  ident: CR24
  article-title: Codon bias and heterologous protein expression
  publication-title: Trends Biotechnol
  doi: 10.1016/j.tibtech.2004.04.006
– volume: 12
  start-page: 857
  issue: 2
  year: 1984
  end-page: 872
  ident: CR33
  article-title: Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/12.2.857
– volume: 16
  start-page: 1
  issue: 1
  year: 2000
  end-page: 15
  ident: CR53
  article-title: Newcastle disease virus (NDV): brief history of its oncolytic strains
  publication-title: J Clin Virol
  doi: 10.1016/S1386-6532(99)00072-4
– volume: 9
  start-page: 40
  year: 2008
  ident: CR66
  article-title: I-TASSER server for protein 3D structure prediction
  publication-title: BMC Bioinform
  doi: 10.1186/1471-2105-9-40
– volume: 14
  start-page: 529
  issue: 8
  year: 2001
  end-page: 532
  ident: CR5
  article-title: Design of the linkers which effectively separate domains of a bifunctional fusion protein
  publication-title: Protein Eng
  doi: 10.1093/protein/14.8.529
– volume: 50
  start-page: 437
  issue: 3
  year: 2003
  end-page: 450
  ident: CR39
  article-title: Structure validation by C-alpha geometry: phi, psi and C-beta deviation
  publication-title: Proteins
  doi: 10.1002/prot.10286
– volume: 20
  start-page: 414
  issue: 4
  year: 2008
  end-page: 425
  ident: CR43
  article-title: Detection of a broad range of class I and II Newcastle disease viruses using a multiplex real-time reverse transcription polymerase chain reaction assay
  publication-title: J Vet Diagn Invest
  doi: 10.1177/104063870802000402
– volume: 42
  start-page: 122
  issue: 1
  year: 2011
  ident: CR16
  article-title: Virulence of newcastle disease virus: what is known so far?
  publication-title: Vet Res
  doi: 10.1186/1297-9716-42-122
– volume: 28
  start-page: 120
  issue: 1
  year: 2009
  end-page: 131
  ident: CR23
  article-title: In silico DNA vaccine designing against human papillomavirus (HPV) causing cervical cancer
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.09.095
– volume: 151
  start-page: 389
  year: 1981
  end-page: 409
  ident: CR29
  article-title: Correlation between the abundance of transfer RNAs and the occurrence of the respective codons in its protein genes: a proposal for a synonymous codon choice that is optimal for the translational system
  publication-title: J Mol Biol
  doi: 10.1016/0022-2836(81)90003-6
– volume: 90
  start-page: 36
  year: 2012
  end-page: 45
  ident: CR45
  article-title: An in silico chimeric multi subunit vaccine targeting virulence factors of enterotoxigenic (ETEC) with its bacterial inbuilt adjuvant
  publication-title: J Microbiol Met
  doi: 10.1016/j.mimet.2012.04.001
– volume: 212
  start-page: 398
  year: 1995
  end-page: 410
  ident: CR40
  article-title: The role of individual oligosaccharide chains in activities of the HN glycoprotein of Newcastle disease virus
  publication-title: Virology
  doi: 10.1006/viro.1995.1497
– volume: 10
  start-page: 26
  issue: 1
  year: 2010
  end-page: 35
  ident: CR44
  article-title: Newcastle disease: evolution of genotypes and the related diagnostic challenges
  publication-title: Infect Genet Evol
  doi: 10.1016/j.meegid.2009.09.012
– year: 2012
  ident: CR13
  article-title: Fusion protein linkers: property, design and functionality
  publication-title: Adv Drug Deliv Rev
– volume: 78
  start-page: 13727
  issue: 24
  year: 2004
  end-page: 13742
  ident: CR50
  article-title: Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state
  publication-title: J Virol
  doi: 10.1128/JVI.78.24.13727-13742.2004
– volume: 42
  start-page: 1349
  issue: 4
  year: 2012
  end-page: 1360
  ident: CR9
  article-title: In silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancer
  publication-title: Amino Acids
  doi: 10.1007/s00726-010-0830-x
– volume: 19
  start-page: 26
  issue: 1
  year: 2001
  end-page: 59
  ident: CR18
  article-title: Intrinsically disordered protein
  publication-title: J Mol Graph Model
  doi: 10.1016/S1093-3263(00)00138-8
– volume: 8
  start-page: 564
  issue: 5
  year: 2010
  end-page: 587
  ident: CR22
  article-title: Plant-specific glycosylation patterns in the context of therapeutic protein production
  publication-title: Plant Biotechnol J
  doi: 10.1111/j.1467-7652.2009.00497.x
– ident: CR46
– volume: 61
  start-page: 437
  issue: 4
  year: 2005
  end-page: 444
  ident: CR55
  article-title: Relationships among stop codon usage bias, its context, isochores, and gene expression level in various eukaryotes
  publication-title: J Mol Evol
  doi: 10.1007/s00239-004-0277-3
– volume: 108
  start-page: 14920
  issue: 36
  year: 2011
  end-page: 14925
  ident: CR64
  article-title: Structure of the Newcastle disease virus hemagglutinin–neuraminidase (HN) ectodomain reveals a four-helix bundle stalk
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1111691108
– start-page: 1305
  year: 2001
  end-page: 1340
  ident: CR38
  article-title: Paramyxoviridae: the viruses and their replication
  publication-title: Fields virology
– volume: 9
  start-page: 443
  issue: 5
  year: 1991
  end-page: 448
  ident: CR59
  article-title: Predicting the solubility of recombinant proteins in
  publication-title: Biotechnology
  doi: 10.1038/nbt0591-443
– volume: 2
  start-page: 75
  year: 2010
  end-page: 84
  ident: CR36
  article-title: In silico sequence specific analysis of ERBB2 RTK alterations responsible for neuroectodermal tumors of Homo sapiens
  publication-title: J Bioinform Seq Anal
– volume: 42
  start-page: 1785
  issue: 8
  year: 2010
  end-page: 1795
  ident: CR56
  article-title: Pathogenicity evaluation of different Newcastle disease virus chimeras in 4-week-old chickens
  publication-title: Trop Anim Health Prod
  doi: 10.1007/s11250-010-9638-7
– volume: 30
  start-page: 1367
  issue: 8
  year: 2011
  end-page: 1382
  ident: CR54
  article-title: Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches
  publication-title: Plant Cell Rep
  doi: 10.1007/s00299-011-1065-3
– volume: 23
  start-page: 2116
  issue: 9
  year: 2006
  end-page: 2121
  ident: CR7
  article-title: Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization
  publication-title: Pharm Res
  doi: 10.1007/s11095-006-9059-5
– volume: 276
  start-page: 172
  issue: 1–2
  year: 1990
  end-page: 174
  ident: CR32
  article-title: A semi-empirical method for prediction of antigenic determinants on protein antigens
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(90)80535-Q
– volume: 14
  start-page: 1191
  year: 2003
  end-page: 1199
  ident: CR61
  article-title: Local complexity of protein sequences
  publication-title: Int J Mod Phys C
  doi: 10.1142/S0129183103005327
– volume: 26
  start-page: 523
  issue: 3
  year: 2009
  end-page: 528
  ident: CR3
  article-title: Insertion of the designed helical linker led to increased expression of tf-based fusion proteins
  publication-title: Pharm Res
  doi: 10.1007/s11095-008-9767-0
– volume: 17
  start-page: 427
  issue: 4
  year: 2007
  end-page: 436
  ident: CR37
  article-title: Structural basis of viral invasion: lessons from paramyxovirus F
  publication-title: Curr Opin Struct Biol
  doi: 10.1016/j.sbi.2007.08.016
– volume: 70
  start-page: 3105
  year: 1989
  end-page: 3109
  ident: CR65
  article-title: Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-70-11-3105
– volume: 1
  start-page: 209
  issue: 3
  year: 2001
  end-page: 219
  ident: CR11
  article-title: Strategies for designing and optimizing new generation vaccines
  publication-title: Nat Rev Immunol
  doi: 10.1038/35105075
– volume: 5
  start-page: 314
  issue: 3
  year: 2001
  end-page: 324
  ident: CR31
  article-title: Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics
  publication-title: Curr Opin Chem Biol
  doi: 10.1016/S1367-5931(00)00208-8
– volume: 13
  start-page: 12
  year: 2007
  end-page: 15
  ident: CR6
  article-title: Economic benefits and costs associated with target vaccinations
  publication-title: J Manag Care Pharm
– volume: 25
  start-page: 5425
  issue: 19
  year: 1986
  end-page: 5432
  ident: CR47
  article-title: New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites
  publication-title: Biochemistry
  doi: 10.1021/bi00367a013
– volume: 9
  start-page: 835
  issue: 8
  year: 2010
  end-page: 842
  ident: CR12
  article-title: Plant glycans: friend or foe in vaccine development?
  publication-title: Expert Rev Vaccines
  doi: 10.1586/erv.10.83
– volume: 2012
  start-page: 708216
  year: 2012
  ident: CR26
  article-title: Avian paramyxovirus serotype-1: a review of disease distribution, clinical symptoms, and laboratory diagnostics
  publication-title: Vet Med Int
  doi: 10.1155/2012/708216
– volume: 45
  start-page: 1
  year: 2007
  end-page: 10
  ident: CR8
  article-title: -glycosylation of recombinant therapeutic glycoproteins in plant systems
  publication-title: Food Technol Biotechnol
– volume: 82
  start-page: 899
  issue: 6
  year: 2003
  end-page: 906
  ident: CR27
  article-title: Recombinant Newcastle disease virus as a vaccine vector
  publication-title: Poult Sci
  doi: 10.1093/ps/82.6.899
– volume: 108
  start-page: 229
  issue: 2
  year: 1989
  end-page: 241
  ident: CR34
  article-title: The scanning model for translation: an update
  publication-title: J Cell Biol
  doi: 10.1083/jcb.108.2.229
– volume: 24
  start-page: 71
  issue: 1
  year: 2000
  end-page: 94
  ident: CR57
  article-title: A global compositional complexity measure for biological sequences: AT-rich and GC-rich genomes encode less complex proteins
  publication-title: Comput Chem
  doi: 10.1016/S0097-8485(00)80008-X
– volume: 140
  start-page: 20
  issue: 1
  year: 1997
  end-page: 22
  ident: CR1
  article-title: Newcastle disease outbreak in pheasants in Great Britain in May 1996
  publication-title: Vet Rec
  doi: 10.1136/vr.140.1.20
– volume: 23
  start-page: 2121
  issue: 17–18
  year: 2005
  end-page: 2131
  ident: CR15
  article-title: Developing an epitope-driven tuberculosis (TB) vaccine
  publication-title: Vaccine
– volume: 283
  start-page: 332
  year: 2001
  end-page: 342
  ident: CR41
  article-title: Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity
  publication-title: Virology
  doi: 10.1006/viro.2001.0899
– volume: 8
  start-page: 4
  year: 2007
  ident: CR17
  article-title: VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines
  publication-title: BMC Bioinform
  doi: 10.1186/1471-2105-8-4
– volume: 12
  start-page: 1
  issue: 251
  year: 2011
  end-page: 13
  ident: CR58
  article-title: Determinants of antigenicity and specificity in immune response for protein sequences
  publication-title: BMC Bioinform
  doi: 10.1093/bib/bbq008
– year: 2005
  ident: CR48
  publication-title: Protein analysis and purification: Bench top techniques
– volume: 2
  start-page: 647
  issue: 4
  year: 2010
  end-page: 666
  ident: CR35
  article-title: Electrostatics in proteins and protein-ligand complexes
  publication-title: Future Med Chem
  doi: 10.4155/fmc.10.6
– volume: 271
  start-page: 144
  year: 1990
  end-page: 146
  ident: CR4
  article-title: Analysis of the stop codon context in plant nuclear genes
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(90)80392-V
– volume: 34
  start-page: 425
  issue: 4
  year: 2004
  end-page: 428
  ident: CR14
  article-title: From genome to vaccine-new immunoinformatics tools for vaccine design
  publication-title: Methods
  doi: 10.1016/j.ymeth.2004.06.004
– volume: 55
  start-page: 836
  issue: 3
  year: 1985
  end-page: 839
  ident: CR20
  article-title: Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide
  publication-title: J Virol
– volume: 24
  start-page: 10
  issue: 1
  year: 2007
  end-page: 12
  ident: CR25
  article-title: Predicting gene expression level from codon usage bias
  publication-title: Mol Biol Evol
  doi: 10.1093/molbev/msl148
– volume: 15
  start-page: 1281
  issue: 3
  year: 1987
  end-page: 1295
  ident: CR52
  article-title: The codon adaptation index–a measure of directional synonymous codon usage bias, and its potential applications
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/15.3.1281
– volume: 285
  start-page: 25
  year: 2005
  end-page: 66
  ident: CR19
  article-title: The many mechanisms of viral membrane fusion proteins
  publication-title: Curr Top Microbiol Immunol
– volume: 9
  start-page: 1082
  year: 2004
  end-page: 1099
  ident: CR10
  article-title: Macroscopic electrostatic models for protonation states in proteins
  publication-title: Front Biosci
  doi: 10.2741/1187
– volume: 877
  start-page: 4015
  issue: 31
  year: 2009
  end-page: 4021
  ident: CR60
  article-title: Protein purification involving a unique auto-cleavage feature of a repeated EAAAK peptide
  publication-title: J Chromatogr B
  doi: 10.1016/j.jchromb.2009.10.009
– volume: 439
  start-page: 38
  year: 2006
  end-page: 44
  ident: CR63
  article-title: Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation
  publication-title: Nature
  doi: 10.1038/nature04322
– volume: 17
  start-page: 427
  issue: 4
  year: 2007
  ident: 9380_CR37
  publication-title: Curr Opin Struct Biol
  doi: 10.1016/j.sbi.2007.08.016
– volume-title: Protein analysis and purification: Bench top techniques
  year: 2005
  ident: 9380_CR48
– volume: 14
  start-page: 529
  issue: 8
  year: 2001
  ident: 9380_CR5
  publication-title: Protein Eng
  doi: 10.1093/protein/14.8.529
– volume: 13
  start-page: 12
  year: 2007
  ident: 9380_CR6
  publication-title: J Manag Care Pharm
  doi: 10.18553/jmcp.2007.13.s7-b.12
– volume: 108
  start-page: 14920
  issue: 36
  year: 2011
  ident: 9380_CR64
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1111691108
– volume: 212
  start-page: 398
  year: 1995
  ident: 9380_CR40
  publication-title: Virology
  doi: 10.1006/viro.1995.1497
– volume: 15
  start-page: 1281
  issue: 3
  year: 1987
  ident: 9380_CR52
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/15.3.1281
– volume: 22
  start-page: 346
  issue: 7
  year: 2004
  ident: 9380_CR24
  publication-title: Trends Biotechnol
  doi: 10.1016/j.tibtech.2004.04.006
– volume: 42
  start-page: 1785
  issue: 8
  year: 2010
  ident: 9380_CR56
  publication-title: Trop Anim Health Prod
  doi: 10.1007/s11250-010-9638-7
– ident: 9380_CR46
  doi: 10.5772/26675
– volume: 78
  start-page: 4176
  issue: 8
  year: 2004
  ident: 9380_CR28
  publication-title: J Virol
  doi: 10.1128/JVI.78.8.4176-4184.2004
– volume: 15
  start-page: 871
  issue: 11
  year: 2002
  ident: 9380_CR21
  publication-title: Protein Eng
  doi: 10.1093/protein/15.11.871
– start-page: 1305
  volume-title: Fields virology
  year: 2001
  ident: 9380_CR38
– volume: 42
  start-page: 1349
  issue: 4
  year: 2012
  ident: 9380_CR9
  publication-title: Amino Acids
  doi: 10.1007/s00726-010-0830-x
– volume: 20
  start-page: 414
  issue: 4
  year: 2008
  ident: 9380_CR43
  publication-title: J Vet Diagn Invest
  doi: 10.1177/104063870802000402
– volume: 34
  start-page: 425
  issue: 4
  year: 2004
  ident: 9380_CR14
  publication-title: Methods
  doi: 10.1016/j.ymeth.2004.06.004
– volume: 140
  start-page: 20
  issue: 1
  year: 1997
  ident: 9380_CR1
  publication-title: Vet Rec
  doi: 10.1136/vr.140.1.20
– volume: 285
  start-page: 25
  year: 2005
  ident: 9380_CR19
  publication-title: Curr Top Microbiol Immunol
– volume: 24
  start-page: 10
  issue: 1
  year: 2007
  ident: 9380_CR25
  publication-title: Mol Biol Evol
  doi: 10.1093/molbev/msl148
– ident: 9380_CR49
– volume: 439
  start-page: 38
  year: 2006
  ident: 9380_CR63
  publication-title: Nature
  doi: 10.1038/nature04322
– volume: 8
  start-page: 564
  issue: 5
  year: 2010
  ident: 9380_CR22
  publication-title: Plant Biotechnol J
  doi: 10.1111/j.1467-7652.2009.00497.x
– volume: 271
  start-page: 144
  year: 1990
  ident: 9380_CR4
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(90)80392-V
– volume: 12
  start-page: 1
  issue: 251
  year: 2011
  ident: 9380_CR58
  publication-title: BMC Bioinform
  doi: 10.1093/bib/bbq008
– volume: 25
  start-page: 5425
  issue: 19
  year: 1986
  ident: 9380_CR47
  publication-title: Biochemistry
  doi: 10.1021/bi00367a013
– volume: 16
  start-page: 1
  issue: 1
  year: 2000
  ident: 9380_CR53
  publication-title: J Clin Virol
  doi: 10.1016/S1386-6532(99)00072-4
– volume: 6
  start-page: 28
  year: 2009
  ident: 9380_CR2
  publication-title: Theor Biol Med Model
  doi: 10.1186/1742-4682-6-28
– volume: 5
  start-page: 314
  issue: 3
  year: 2001
  ident: 9380_CR31
  publication-title: Curr Opin Chem Biol
  doi: 10.1016/S1367-5931(00)00208-8
– volume: 8
  start-page: 4
  year: 2007
  ident: 9380_CR17
  publication-title: BMC Bioinform
  doi: 10.1186/1471-2105-8-4
– volume: 70
  start-page: 3105
  year: 1989
  ident: 9380_CR65
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-70-11-3105
– volume: 9
  start-page: 40
  year: 2008
  ident: 9380_CR66
  publication-title: BMC Bioinform
  doi: 10.1186/1471-2105-9-40
– volume: 24
  start-page: 71
  issue: 1
  year: 2000
  ident: 9380_CR57
  publication-title: Comput Chem
  doi: 10.1016/S0097-8485(00)80008-X
– volume: 25
  start-page: 591
  issue: 4
  year: 2007
  ident: 9380_CR62
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.08.016
– volume: 1
  start-page: 209
  issue: 3
  year: 2001
  ident: 9380_CR11
  publication-title: Nat Rev Immunol
  doi: 10.1038/35105075
– volume: 9
  start-page: 443
  issue: 5
  year: 1991
  ident: 9380_CR59
  publication-title: Biotechnology
  doi: 10.1038/nbt0591-443
– volume: 23
  start-page: 2121
  issue: 17–18
  year: 2005
  ident: 9380_CR15
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.01.059
– volume: 14
  start-page: 1191
  year: 2003
  ident: 9380_CR61
  publication-title: Int J Mod Phys C
  doi: 10.1142/S0129183103005327
– volume: 23
  start-page: 2116
  issue: 9
  year: 2006
  ident: 9380_CR7
  publication-title: Pharm Res
  doi: 10.1007/s11095-006-9059-5
– volume: 2
  start-page: 647
  issue: 4
  year: 2010
  ident: 9380_CR35
  publication-title: Future Med Chem
  doi: 10.4155/fmc.10.6
– volume: 10
  start-page: 26
  issue: 1
  year: 2010
  ident: 9380_CR44
  publication-title: Infect Genet Evol
  doi: 10.1016/j.meegid.2009.09.012
– volume: 82
  start-page: 899
  issue: 6
  year: 2003
  ident: 9380_CR27
  publication-title: Poult Sci
  doi: 10.1093/ps/82.6.899
– volume: 2012
  start-page: 708216
  year: 2012
  ident: 9380_CR26
  publication-title: Vet Med Int
  doi: 10.1155/2012/708216
– volume: 2
  start-page: 75
  year: 2010
  ident: 9380_CR36
  publication-title: J Bioinform Seq Anal
– volume: 45
  start-page: 1
  year: 2007
  ident: 9380_CR8
  publication-title: Food Technol Biotechnol
– volume: 28
  start-page: 120
  issue: 1
  year: 2009
  ident: 9380_CR23
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.09.095
– volume: 276
  start-page: 172
  issue: 1–2
  year: 1990
  ident: 9380_CR32
  publication-title: FEBS Lett
  doi: 10.1016/0014-5793(90)80535-Q
– volume: 108
  start-page: 229
  issue: 2
  year: 1989
  ident: 9380_CR34
  publication-title: J Cell Biol
  doi: 10.1083/jcb.108.2.229
– volume: 78
  start-page: 13727
  issue: 24
  year: 2004
  ident: 9380_CR50
  publication-title: J Virol
  doi: 10.1128/JVI.78.24.13727-13742.2004
– volume: 55
  start-page: 836
  issue: 3
  year: 1985
  ident: 9380_CR20
  publication-title: J Virol
  doi: 10.1128/JVI.55.3.836-839.1985
– volume: 9
  start-page: 835
  issue: 8
  year: 2010
  ident: 9380_CR12
  publication-title: Expert Rev Vaccines
  doi: 10.1586/erv.10.83
– year: 2012
  ident: 9380_CR13
  publication-title: Adv Drug Deliv Rev
– volume: 9
  start-page: 1082
  year: 2004
  ident: 9380_CR10
  publication-title: Front Biosci
  doi: 10.2741/1187
– volume: 61
  start-page: 437
  issue: 4
  year: 2005
  ident: 9380_CR55
  publication-title: J Mol Evol
  doi: 10.1007/s00239-004-0277-3
– volume: 877
  start-page: 4015
  issue: 31
  year: 2009
  ident: 9380_CR60
  publication-title: J Chromatogr B
  doi: 10.1016/j.jchromb.2009.10.009
– volume: 26
  start-page: 523
  issue: 3
  year: 2009
  ident: 9380_CR3
  publication-title: Pharm Res
  doi: 10.1007/s11095-008-9767-0
– volume: 65
  start-page: 4999
  issue: 9
  year: 1991
  ident: 9380_CR30
  publication-title: J Virol
  doi: 10.1128/JVI.65.9.4999-5006.1991
– volume: 30
  start-page: 1367
  issue: 8
  year: 2011
  ident: 9380_CR54
  publication-title: Plant Cell Rep
  doi: 10.1007/s00299-011-1065-3
– volume: 20
  start-page: 489
  issue: 3
  year: 2007
  ident: 9380_CR42
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00005-07
– volume: 12
  start-page: 857
  issue: 2
  year: 1984
  ident: 9380_CR33
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/12.2.857
– volume: 50
  start-page: 437
  issue: 3
  year: 2003
  ident: 9380_CR39
  publication-title: Proteins
  doi: 10.1002/prot.10286
– volume: 19
  start-page: 293
  issue: 8
  year: 2001
  ident: 9380_CR51
  publication-title: Trends Biotechnol
  doi: 10.1016/S0167-7799(01)01670-5
– volume: 283
  start-page: 332
  year: 2001
  ident: 9380_CR41
  publication-title: Virology
  doi: 10.1006/viro.2001.0899
– volume: 90
  start-page: 36
  year: 2012
  ident: 9380_CR45
  publication-title: J Microbiol Met
  doi: 10.1016/j.mimet.2012.04.001
– volume: 19
  start-page: 26
  issue: 1
  year: 2001
  ident: 9380_CR18
  publication-title: J Mol Graph Model
  doi: 10.1016/S1093-3263(00)00138-8
– volume: 151
  start-page: 389
  year: 1981
  ident: 9380_CR29
  publication-title: J Mol Biol
  doi: 10.1016/0022-2836(81)90003-6
– volume: 42
  start-page: 122
  issue: 1
  year: 2011
  ident: 9380_CR16
  publication-title: Vet Res
  doi: 10.1186/1297-9716-42-122
SSID ssj0052710
Score 2.0357065
Snippet Application of molecular biology techniques to the production of new vaccines against different strains of the Newcastle disease virus (NDV) has been the...
SourceID proquest
crossref
springer
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 179
SubjectTerms Animal Anatomy
Antigens
Biochemistry
Biomedical and Life Sciences
Glycoproteins
Histology
Life Sciences
Molecular biology
Molecular Medicine
Morphology
Newcastle disease virus
Peptides
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Polymer Sciences
Viral infections
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB6a9NBcQl6lm0eZQOmhQcTyW6ewbLJsCl0KbcLejCxLYWFjJ_EuJP8-GtnebQPZqy1Z4E-PGX0z3wB8EzIIhfUcWGESzUKR2zWXiphJz2gqJ5LHTrvz1zge3YQ_J9GkvXCr27DKbk90G3VRKbojP6eTiUihiF88PDKqGkXsaltCYwM-knQZzepksnS4Ij9p1AiihHLIQtGxmk3qnAsW4gETQeqx5__PpZWx-YYfdcfOcAe2W3sR-w3Au_BBl3uw3y-tr3z_gt_RRXC6q_E9-DToqrftQ31d4p_pzOKMly5IAyuDLtvWUTQ4GrMh9ss5iXGirFEiRXzMXvCaEkYq-9Q2-k0hL4XGW6mIf8f-nZxacxLHVHWE-GG8bPgdvJ0-LeoDuBle_R2MWFtggSmL0JwVRRQkukgNL3JlNIkcCdKTi5U2QuVxJK11JnxfacmN5nT7ICjZ2hif556F-TNsllWpvwDaDonkQZRKySmZV6aRkoZrFSgZFLHqgdf93ky16uNUBGOWrXSTCZHMIpIRItlzD34suzw00hvrGh93mGXtKqyz1ZzpwenytQWCSBFZ6mpBbXwvSK0bmfbgrMP6n0-8N-Dh-gGPYMuaVmETVHYMm_OnhT6x5ss8_-rm6CsTHerp
  priority: 102
  providerName: ProQuest
Title In Silico Design of Multimeric HN-F Antigen as a Highly Immunogenic Peptide Vaccine Against Newcastle Disease Virus
URI https://link.springer.com/article/10.1007/s10989-013-9380-x
https://www.proquest.com/docview/1512823051
https://www.proquest.com/docview/1520386198
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1db9MwFL2C7QFeEGwgCqO6SIgHkKU4334MW0sHopqATuUpchwbVSopWlqJ_XvudZJtIEDiKVJy7Ug5sX3scz8AXigdxYp2DqJ2mRWxqmjM5SoVOnCWy4lUqc_d-WGezhbxu2Wy7OO428HbfZAk_Ux9I9jNu_fISKgoDwQRx_2Etu7sx7UIi2H6TcKsS0GQZBw4FqtByvxTF78uRtcM8zdR1K810_twryeJWHSoPoBbtjmAw6KhDfK3S3yJ3m3Tn4cfwJ3joWTbIbSnDX5arQlcPPGeGbhx6ENsvS6Ds7mYYtFsOQMn6hY1spvH-hJPOUpkQ3fJ6Iz9XGqL59qw6I7FV70iDolzLjXCojCedKIOnq8udu1DWEwnn49noq-qIAzBshV1nUSZrXMn68o4y5mNFCeRS411ylRpoomSqTA0VktnJR85KI6wdi6UVUDYPoK9ZtPYx4DUINMySnKtJUfw6jwx2klrIqOjOjUjCIbPW5o-5ThXvliX18mSGZGSECkZkfLHCF5dNfne5dv4l_HRgFnZD722ZArD6mEiR_D86jEBwUqIbuxmxzZhEOW0d8xH8HrA-kYXf3vhk_-yfgp3iV7FnWPZEextL3b2GVGYbTWG29kyG8N-8fbL-wld30zmZx_H_kf-CRvC7Ds
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VcigXBC2I0AKDBBxAK_y294BQ1BAltI2QaKvczHq9iyIFu20S0fwpfiMz6zgBJHrr1d6HvTO7M7PfPABeSRVGkiwHUdrUiEgWtOcymQjlWcPlRIrE5e48GSWDs-jzOB5vwa82FobdKtsz0R3UZa35jvw9SyYGhWL_48Wl4KpRjK62JTQatjgyy59kss0-DHtE39dB0P90ejgQq6oCQtNnzUVZxmFqysz6ZaGt4cw-kpOoJdpYqYskVqSSyCDQRvnW-GxyS44wtjbwC4_-jca9A3dJ8Hps7KXjtYEXB2mT_SBOOWYtki2K2oTqOeckPxQyzDxx_bcc3Ci3_-CxTsz1H8D9lX6K3YahHsKWqXZhr1uRbf5jiW_QeYy6q_hd2Dlsq8XtwWxY4dfJlPgKe84pBGuLLrrXQUI4GIk-dqs5J_9ENUOF7GEyXeKQA1RqekqNvrCLTWnwXGnG-7H7XU1IfcURVzlhPBp7DZ6E55OrxewRnN3K0j-G7aquzBNA6pAqP4wzpXwOHlZZrJX1jQ61CstEd8BrlzfXq2znXHRjmm_yNDNFcqJIzhTJrzvwdt3lokn1cVPjg5Zm-WrXz_INj3bg5fo1EYJBGFWZesFtAi_MyGzNOvCupfUfQ_xvwqc3T_gCdganJ8f58XB0tA_3SK2LGoe2A9ieXy3MM1Kd5sVzx68I3257g_wGqhMoGw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVAIuCFoQKQUGCTiArPpt7wGh0DRKKFgR0Ko3d73erSIFu9SJaP4av44ZPxpAorde7X3YO7M7M_vNA-ClkJ4vyHKwchNpyxcZ7blYhJa0jeZyIllY5-78nITjI__jSXCyAb-6WBh2q-zOxPqgzkvFd-R7LJkYFAqcPdO6RUyHo_fnPyyuIMVIa1dOo2GRQ736SeZb9W4yJFq_ct3Rwbf9sdVWGLAUfeLCyvPAi3QeGyfPlNGc5UdwQrVQaSNUFgaS1BPhukpLx2iHzW_B0cbGuE5m03_SuLdgM2KrqAebHw6S6ZdODgRu1ORCCCKOYPNFh6k2gXu1q5LjWcKLbevyb6m4VnX_QWdroTe6D_dabRUHDXs9gA1dbMH2oCBL_fsKX2PtP1pfzG_Bnf2udtw2VJMCv87mxGU4rF1EsDRYx_rWABGOE2uEg2LBqUBRViiR_U3mK5xwuEpJT6nRlB1uco3HUjH6j4MzOSNlFhOuecLoNA4bdAmPZxfL6iEc3cjiP4JeURb6MSB1iKTjBbGUDocSyzhQ0jhaeUp6eaj6YHfLm6o29zmX4Jin66zNTJGUKJIyRdLLPry56nLeJP64rvFuR7O0PQOqdM2xfXhx9ZoIwZCMLHS55Dau7cVkxMZ9eNvR-o8h_jfhzvUTPofbtDnST5Pk8AncJR3Pb7zbdqG3uFjqp6RHLbJnLcMinN70HvkNmZ8ttg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Silico+Design+of+Multimeric+HN-F+Antigen+as+a+Highly+Immunogenic+Peptide+Vaccine+Against+Newcastle+Disease+Virus&rft.jtitle=International+journal+of+peptide+research+and+therapeutics&rft.au=Motamedi%2C+Mohammad+Javad&rft.au=Amani%2C+Jafar&rft.au=Shahsavandi%2C+Shahla&rft.au=Salmanian%2C+Ali+Hatef&rft.date=2014-06-01&rft.pub=Springer+Netherlands&rft.issn=1573-3149&rft.eissn=1573-3904&rft.volume=20&rft.issue=2&rft.spage=179&rft.epage=194&rft_id=info:doi/10.1007%2Fs10989-013-9380-x&rft.externalDocID=10_1007_s10989_013_9380_x
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1573-3149&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1573-3149&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1573-3149&client=summon